ASP Isotopes (NASDAQ:ASPI) Given Buy Rating at Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of ASP Isotopes (NASDAQ:ASPI) in a report released on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a $4.50 price target on the stock.

A number of other analysts have also weighed in on ASPI. HC Wainwright lowered their price target on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th. Canaccord Genuity Group started coverage on shares of ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 price target for the company.

ASP Isotopes Stock Performance

NASDAQ ASPI opened at $4.28 on Friday. The firm has a market cap of $221.55 million, a price-to-earnings ratio of -8.08 and a beta of 5.11. The company has a 50 day moving average of $2.66 and a 200-day moving average of $3.25. The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06. ASP Isotopes has a 1-year low of $0.98 and a 1-year high of $5.67.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The firm had revenue of $1.02 million for the quarter. On average, equities analysts forecast that ASP Isotopes will post -0.24 earnings per share for the current fiscal year.

Institutional Trading of ASP Isotopes

A number of institutional investors have recently bought and sold shares of ASPI. Vanguard Group Inc. grew its holdings in ASP Isotopes by 479.1% during the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after acquiring an additional 844,705 shares during the period. Marshall Wace LLP boosted its position in shares of ASP Isotopes by 389.6% during the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after purchasing an additional 433,734 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of ASP Isotopes during the second quarter worth $381,000. HTLF Bank boosted its position in shares of ASP Isotopes by 197.0% during the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock worth $323,000 after purchasing an additional 70,000 shares in the last quarter. Finally, Virtu Financial LLC boosted its position in shares of ASP Isotopes by 477.0% during the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after purchasing an additional 69,176 shares in the last quarter. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.